Amprologix secures £740,000 in pre-Series A funding for antibiotic development
PositiveFinancial Markets

Amprologix has successfully secured £740,000 in pre-Series A funding to advance its antibiotic development efforts. This funding is crucial as it will enable the company to enhance its research and development capabilities, potentially leading to innovative solutions in combating antibiotic resistance. The investment highlights the growing interest in antibiotic research, which is vital for public health.
— Curated by the World Pulse Now AI Editorial System